PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE
Clinical trials for PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE explained in plain language.
Never miss a new study
Get alerted when new PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE trials appear
Sign up with your email to follow new studies for PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo could help heart defect patients with severe lung pressure
Disease control Recruiting nowThis study tests whether adding the drug sotatercept to usual treatments can improve exercise ability in adults with pulmonary arterial hypertension (PAH) from unrepaired heart defects, including Eisenmenger syndrome. About 36 adults in Japan will be randomly assigned to receive …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE
Phase: PHASE4 • Sponsor: Kazuya Hosokawa • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Could your genes predict lung disease? 10,000-Person study seeks answers
Knowledge-focused Recruiting nowThis study looks at how genes may increase the risk of pulmonary hypertension (high blood pressure in the lungs). Researchers will collect health surveys and saliva samples from 10,000 adults in the US, both with and without the condition. The goal is to find genetic links that c…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE
Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC